Our experience with postoperative adjuvant abdomino-pelvic radiotherapy after surgery and chemotherapy for advanced ovarian cancer. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I ...
Two Articles published Online first and in an upcoming edition of The Lancet show that two common adjuvant treatments for women with early endometrial cancer — removing the pelvic lymph nodes or ...
The addition of pelvic lymph node treatment and short-term androgen deprivation therapy to prostate bed salvage radiotherapy reduced risk for disease progression among men with prostate cancer, ...
Patients with high-risk localized or locally advanced prostate cancer treated with IMRT in the English National Health Service between 2010 and 2013 were identified by using data from the Cancer ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...
Removing lymph nodes that appear unaffected by ovarian cancer won’t help and might hurt. If advanced ovarian cancer has not visibly spread to a patient’s lymph nodes, removing the nodes is not only ...
Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...
Metastatic endometrial cancer can affect distant areas of the body, such as the lungs, liver, bones, or brain. Treatments may include surgery alongside radiation therapy, chemotherapy, or other drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback